


Ask a doctor about a prescription for OLMESARTAN/HYDROCHLOROTHIAZIDE NORMON 40 mg/25 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Olmesartan/Hydrochlorothiazide Normon 40 mg/25 mg film-coated tablets EFG
Olmesartan Medoxomil/Hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the pack
Olmesartan/Hydrochlorothiazide Normon contains two active substances, olmesartan medoxomil and hydrochlorothiazide, which are used in the treatment of high blood pressure (hypertension):
Olmesartan/Hydrochlorothiazide Normon will only be given if treatment with olmesartan medoxomil alone has not adequately controlled your blood pressure. The combination of the two active substances in Olmesartan/Hydrochlorothiazide Normon helps to lower blood pressure more than either substance on its own.
You may already be taking medicines to treat high blood pressure, but your doctor may think it is necessary for you to take Olmesartan/Hydrochlorothiazide Normon to lower it further.
High blood pressure can be controlled with medicines such as Olmesartan/Hydrochlorothiazide Normon tablets. Your doctor may also have recommended that you make some changes to your lifestyle, such as losing weight, stopping smoking, reducing alcohol intake, and reducing the amount of salt in your diet. Your doctor may also have recommended that you exercise regularly, such as walking or swimming. It is important to follow your doctor's advice.
Do not take Olmesartan/Hydrochlorothiazide Normon
If you think any of these apply to you, or if you are unsure, do not take the tablets. Talk to your doctor and follow their advice.
Warnings and precautions
Consult your doctor before starting to take Olmesartan/Hydrochlorothiazide Normon
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Olmesartan/Hydrochlorothiazide Normon. Your doctor will decide whether to continue treatment. Do not stop taking Olmesartan/Hydrochlorothiazide Normon on your own.
If you experience a decrease in vision or eye pain, these could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase in eye pressure, and can occur within a few hours to a week after taking Olmesartan/Hydrochlorothiazide Normon. This can lead to permanent vision loss if not treated. If you have previously had an allergy to penicillin or sulphonamides, you may be at greater risk of developing it.
Before taking the tablets, tell your doctorif you are taking any of the following medicines used to treat high blood pressure (hypertension):
Your doctor may want to check your kidney function, blood pressure, and blood electrolyte levels at regular intervals.
See also the information under the heading “Do not take Olmesartan/Hydrochlorothiazide Normon”.
Before taking the tablets, tell your doctorif you have any of the following health problems:
Contact your doctor if you experience severe, persistent diarrhea that causes significant weight loss. Your doctor will assess your symptoms and decide how to proceed with your blood pressure treatment.
Your doctor may want to see you more often and perform some tests if you have any of these problems.
Olmesartan/Hydrochlorothiazide Normon may cause an increase in blood fat and uric acid levels (which can cause gout - painful swelling of the joints). Your doctor will probably want to perform a blood test from time to time to check for these possible changes.
A change in blood levels of certain chemicals called electrolytes may occur. Your doctor will probably want to perform a blood test from time to time to check for this possible change. Some signs of electrolyte changes are: thirst, dry mouth, muscle pain or cramps, tired muscles, low blood pressure (hypotension), feeling of weakness, slowness, tiredness, drowsiness or restlessness, nausea, vomiting, decreased need to urinate, rapid heartbeat. Tell your doctor if you notice any of these symptoms.
As with any other medicine that lowers blood pressure, excessive lowering of blood pressure in patients with impaired blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
If you are going to have parathyroid function tests, you should stop taking Olmesartan/Hydrochlorothiazide Normon before these tests are performed.
Athletes are informed that this medicine contains a component that may result in a positive doping test.
You must inform your doctor if you are pregnant or think you might be. Your doctor will advise you to stop taking Olmesartan/Hydrochlorothiazide Normon before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Olmesartan/Hydrochlorothiazide Normon. It is not recommended to take Olmesartan/Hydrochlorothiazide Normon during pregnancy, and it must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken after the third month of pregnancy.
Children and adolescents
Olmesartan/Hydrochlorothiazide Normon is not recommended for children and adolescents under 18 years of age.
Using Olmesartan/Hydrochlorothiazide Normon with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
In particular, tell your doctor or pharmacist about any of the following medicines:
Taking Olmesartan/Hydrochlorothiazide Normon with food and drink
Olmesartan/Hydrochlorothiazide Normon can be taken with or without food.
Be careful when drinking alcohol while taking Olmesartan/Hydrochlorothiazide Normon, as some people feel weak or dizzy. If this happens, do not drink any alcohol, including wine, beer, or alcoholic drinks.
Black patients
As with other similar medicines, the blood pressure-lowering effect of Olmesartan/Hydrochlorothiazide Normon is somewhat smaller in black patients.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you are pregnant or think you might be. Your doctor will advise you to stop taking Olmesartan/Hydrochlorothiazide Normon before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Olmesartan/Hydrochlorothiazide Normon. It is not recommended to take Olmesartan/Hydrochlorothiazide Normon during pregnancy, and it must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken after the third month of pregnancy.
Breastfeeding
Tell your doctor if you are breastfeeding or about to start breastfeeding. Olmesartan/Hydrochlorothiazide Normon is not recommended for breastfeeding mothers, and your doctor may choose another treatment if you want to breastfeed.
If you are pregnant or breastfeeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Use in athletes
Athletes are informed that this medicine contains a component (hydrochlorothiazide) that may result in a positive doping test.
Driving and using machines
You may feel drowsy or dizzy while being treated for high blood pressure. If this happens, do not drive or use machines until the symptoms have disappeared. Consult your doctor.
Olmesartan/Hydrochlorothiazide Normon contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor or pharmacist again.
The recommended doseis one Olmesartan/Hydrochlorothiazide Normon 40 mg/12.5 mg tablet per day. If your blood pressure is not adequately controlled, your doctor may change the dose to one Olmesartan/Hydrochlorothiazide Normon 40 mg/25 mg tablet per day.
Take the tablets with water. If possible, take your dose at the same time each day, for example, at breakfast time. It is important that you continue to take Olmesartan/Hydrochlorothiazide Normon until your doctor tells you to stop.
If you take more Olmesartan/Hydrochlorothiazide Normon than you should
If you take more tablets than you should or if a child accidentally swallows one or more tablets, contact your doctor or go to the nearest hospital emergency department immediately and take the medicine pack with you.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, telephone 91 562 04 20, stating the medicine and the amount taken.
If you forget to take Olmesartan/Hydrochlorothiazide Normon
If you forget to take a daily dose, take your usual dose the next day. Do nottake a double dose to make up for forgotten doses.
If you stop taking Olmesartan/Hydrochlorothiazide Normon
It is important to continue taking Olmesartan/Hydrochlorothiazide Normon unless your doctor tells you to stop.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
However, the following adverse effects may be serious:
Olmesartán/Hidroclorotiazida Normon is a combination of two active ingredients. The following information first describes the adverse effects reported so far with the combination Olmesartán/Hidroclorotiazida (in addition to those already mentioned) and, secondly, the known adverse effects of the two active ingredients separately.
These are other known adverse effects so far with the combination Olmesartán/Hidroclorotiazida:
If these effects occur, they are often mild and it is not necessary to interrupt treatment.
Common Adverse Effects (may affect up to 1 in 10 people):
Dizziness, weakness, headache, fatigue, chest pain, swelling of ankles, feet, legs, hands, or arms.
Uncommon Adverse Effects (may affect up to 1 in 100 people):
Fast and intense heartbeat (palpitations), rash, eczema, vertigo, cough, indigestion, abdominal pain, nausea, vomiting, diarrhea, muscle cramps, and muscle pain, joint pain, arm and leg pain, back pain, erection problems in men, blood in urine.
Also, some changes in blood tests have been observed infrequently, including: Increased levels of fat in the blood, increased urea or uric acid in the blood, increased creatinine, increased or decreased potassium levels in the blood, increased calcium levels in the blood, increased blood sugar, increased liver function test values. Your doctor will monitor you with a blood test and tell you if you need to take any action.
Rare Adverse Effects (may affect up to 1 in 1,000 people):
Feeling unwell, altered consciousness, skin swelling (hives), acute kidney failure.
Also, some changes in blood test results have been observed in rare cases, including:
Increased blood urea nitrogen, decreased hemoglobin and hematocrit values. Your doctor will monitor you with a blood test and tell you if you need to take any action.
Intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Additional Adverse Effects Reported with the Use of Olmesartán Medoxomil or Hidroclorotiazida Alone, but not with the Combination Olmesartán/Hidroclorotiazida or at a Higher Frequency:
Olmesartán Medoxomil:
Common Adverse Effects (may affect up to 1 in 10 people):
Bronchitis, cough, nasal congestion and secretion, sore throat, abdominal pain, indigestion, diarrhea, nausea, gastroenteritis, joint or bone pain, back pain, blood in urine, urinary tract infection, flu-like symptoms, pain.
Also, some changes in blood test results have been observed frequently, including:
Increased levels of fat in the blood, increased urea or uric acid in the blood, increased liver or muscle function test values.
Uncommon Adverse Effects (may affect up to 1 in 100 people):
Rapid allergic reactions that can affect the whole body and cause breathing problems, as well as a rapid drop in blood pressure that can lead to fainting (anaphylactic reactions), facial inflammation, angina (chest pain or discomfort, known as angina pectoris), feeling unwell, allergic skin rash, itching, exanthema (skin rash), skin swelling (hives).
Also, some changes in blood test results have been observed infrequently, including:
Decreased number of a type of blood cells called platelets (thrombocytopenia).
Rare Adverse Effects (may affect up to 1 in 1,000 people):
Kidney function deterioration, lack of energy.
Also, some changes in blood test results have been observed rarely, including:
Increased potassium in the blood.
Hidroclorotiazida:
Very Common Adverse Effects (may affect more than 1 in 10 people):
Changes in blood tests, including: increased fat in the blood and uric acid levels.
Common Adverse Effects (may affect up to 1 in 10 people):
Feeling of confusion, abdominal pain, stomach discomfort, feeling of bloating, diarrhea, nausea, vomiting, constipation, glucose in urine.
Also, some changes in blood test results have been observed, including:
Increased creatinine, urea, calcium, and blood sugar levels, decreased chloride, potassium, magnesium, and sodium levels in the blood. Increased serum amylase (hyperamylasemia).
Uncommon Adverse Effects (may affect up to 1 in 100 people):
Decreased or lost appetite, severe breathing difficulties, anaphylactic skin reactions (hypersensitivity reactions), worsening of pre-existing myopia, erythema, skin reactions due to light sensitivity, itching, purple spots or patches on the skin due to small hemorrhages (purpura), skin swelling (hives).
Rare Adverse Effects (may affect up to 1 in 1,000 people):
Inflammation and pain of the salivary glands, decreased number of white blood cells, decreased number of platelets in the blood, anemia, bone marrow depression, restlessness, depression, sleep problems, feeling of loss of interest (apathy), tingling and numbness, seizures (convulsions), yellow vision, blurred vision, dry eyes, irregular heartbeat, inflammation of blood vessels, blood clots (thrombosis or embolism), lung inflammation, fluid accumulation in the lungs, pancreatitis, jaundice, gallbladder infection, symptoms of lupus erythematosus (such as skin rash, joint pain, and cold hands and fingers), allergic skin reactions, skin peeling and blisters, non-infectious kidney inflammation (interstitial nephritis), fever, muscle weakness (which can cause movement disorders).
Very Rare Adverse Effects (may affect up to 1 in 10,000 people):
Electrolyte imbalance that can cause an abnormally low level of chloride in the blood (hypochloremic alkalosis), intestinal obstruction (paralytic ileus).
Acute respiratory distress (signs include severe respiratory distress, fever, weakness, and confusion).
Adverse Effects of Unknown Frequency:Skin and lip cancer (non-melanoma skin cancer).
Decreased vision or eye pain due to high pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma].
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiration date that appears on the packaging and on the blister pack (after "CAD"). The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Olmesartán/Hidroclorotiazida Normon
The active ingredients are:
Olmesartán/Hidroclorotiazida Normon 40 mg/25 mg: each film-coated tablet contains 40 mg of olmesartán medoxomil and 25 mg of hidroclorotiazida.
The other components (excipients) are: lactose monohydrate*, hydroxypropylcellulose (E463), low-substituted hydroxypropyl cellulose, microcrystalline cellulose, magnesium stearate, hypromellose, titanium dioxide (E 171), macrogol 6000, talc, red iron oxide (E 172), and yellow iron oxide (E 172).
Appearance of the Product and Package Contents
Olmesartán/Hidroclorotiazida Normon 40 mg/25 mg is presented in the form of film-coated tablets, pink, elliptical, biconvex, and serigraphed.
Olmesartán/Hidroclorotiazida Normon 40 mg/25 mg film-coated tablets are presented in a package of 28 tablets.
Marketing Authorization Holder and Manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of the Last Revision of this Prospectus:February 2025
Other Sources of Information
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.
The average price of OLMESARTAN/HYDROCHLOROTHIAZIDE NORMON 40 mg/25 mg FILM-COATED TABLETS in October, 2025 is around 20.18 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OLMESARTAN/HYDROCHLOROTHIAZIDE NORMON 40 mg/25 mg FILM-COATED TABLETS – subject to medical assessment and local rules.